课题基金 / 基金详情

ANTI-HIV POTENTIAL OF PENTOSAN POLYSULFATE

ANTI-HIV POTENTIAL OF PENTOSAN POLYSULFATE
戊聚糖多硫酸酯的抗 HIV 潜力
批准号:
3901023
负责人:
L B BIGELOW
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

L B BIGELOW的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Pentosan polysulfate (PPS), a semi-synthetic polyanion, has been under investigation here for a number of years as a prophylactic treatment for migraine and cluster headache. Since we observed an increase of circulating T-cells in treated patients and because of the reported synergism of another sulfated polyanion, dextran sulfate, with AZT, we have performed in-vitro experiments to evaluate the therapeutic potential of this drug. Using human peripheral blood mononuclear cells we have been able to demonstrate synergism of PPS with aziduvine (AZT) in the suppression of HIV-1 growth. We also observed that PPS and dextran sulfate alone in concentrations less than 1.Omug/ml stimulated viral replication. This latter finding is particularly important because of the reported "underground market" for dextran sulfate. It suggests that persons with AIDS could actually worsen their condition if they were to take polyanions such as dextran. On the other hand, the finding of a powerful synergism between AZT and PPS gives encouragement to careful design of clinical research to evaluate this substance as an adjunct to the treatment of AIDS that might permit effective lower dosing of AZT.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TREATMENT OF MIGRAINE WITH ANIONIC POLYELECTROLYTES
PENTOSAN POLYSULFATE AS PROPHYLAXIS FOR MIGRAINE
CHRONIC AMPHETAMINE ADMINISTRATION IN SCHIZOPHRENIA
THE BRIEF PSYCHIATRIC RATING SCALE AS A WARD DAILY RATING SYSTEM
海外基金